This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Alexander Martin Pawliczek: Innovator in Heterocyclic Compounds
Introduction
Alexander Martin Pawliczek is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds. With a total of 5 patents to his name, Pawliczek's work focuses on innovative solutions for medical conditions.
Latest Patents
Pawliczek's latest patents include a heterocyclic compound that exhibits orexin type 2 receptor agonist activity. This compound is represented by a specific formula and is designed to be useful as an agent for the prophylaxis or treatment of narcolepsy. His work in this area highlights the potential for new therapeutic approaches to managing sleep disorders.
Career Highlights
Pawliczek is currently employed at Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His expertise in heterocyclic compounds has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Yasushi Hattori and Yuhei Miyanohana, who contribute to the collaborative environment at Takeda Pharmaceutical Company Limited.
Conclusion
Alexander Martin Pawliczek is a distinguished inventor whose work in heterocyclic compounds is paving the way for innovative treatments in the pharmaceutical field. His contributions are essential for advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile